Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Kedudukan dalam Saham
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Harga Saham
$8.03
Modal Pasaran
$6.31B
Perubahan (1 hari)
1.07%
Perubahan (1 tahun)
-8.04%
Negara
CN
Perdagangan Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategori
Healthcare
Pendapatan untuk Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Pendapatan pada Jun 2026 TTM: $294.96M
Menurut laporan kewangan terkini Shenzhen New Industries Biomedical Engineering Co., Ltd., pendapatan semasa syarikat ialah $294.96M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $286.77M, peningkatan berbanding pendapatan pada tahun 2023 yang berjumlah $267.43M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Shenzhen New Industries Biomedical Engineering Co., Ltd. dari 2012 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $294.96M | 11.23% |
| 2025 | $265.17M | -7.53% |
| 2024 | $286.77M | 7.23% |
| 2023 | $267.43M | 22.88% |
| 2022 | $217.63M | 21.82% |
| 2021 | $178.66M | 6.41% |
| 2020 | $167.89M | 30.12% |
| 2019 | $129.03M | 9.95% |
| 2018 | $117.35M | 21.27% |
| 2017 | $96.77M | 27.14% |
| 2016 | $76.11M | 69.74% |
| 2015 | $44.84M | -6.42% |
| 2014 | $47.91M | 76.41% |
| 2013 | $27.16M | 94.24% |
| 2012 | $13.98M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $6.56B | 2,124.73% |
US
|
|
| $6.60B | 2,138.63% |
IE
|
|
| $5.15B | 1,645.34% |
US
|
|
| $3.86B | 1,209.00% |
US
|
|
| $3.25B | 1,001.86% |
DE
|
